Journal - Canadian Dental Association = Journal de l'Association dentaire canadienne
-
Randomized Controlled Trial Clinical Trial
Efficacy of ketorolac in the management of pain associated with root canal treatment.
Patients requiring root canal treatment were randomly assigned to one of three groups. The first group received Ketorolac oral 10 mg at six hour intervals for 24 hours, the second group received Ketorolac (Toradol) injectable 10 mg at the height/depth of the buccal vestibule of the tooth to be treated, and the third group received no assigned medication. ⋯ Some of the patients in the Ketorolac injectable group felt that an additional dose of medication would have been helpful at the six- to eight-hour postoperative period. However, there was no significant difference in pain relief between the two groups treated with different drug regimens.